Rentosertib now joins the list of recognized drug candidates and will be referred to by this name ... Key findings from the Phase IIa trial include: Dose-dependent improvements in lung function: ...

A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib-an FDA-approved ...